New
ScienceMore in Science→
Michigan Drug Candidate Reversed Severe Fatty Liver Disease in Animals
Key Takeaways
- DT-109 reversed MASH in animal studies.
- The compound was reported to protect the intestinal barrier and reduce harmful microbial products.
- Human clinical testing is still needed.
DE
DT Editorial Team··via sciencedaily.com